Skip to Main Content
  • Login
  • Contact Us
  • Donate

NANETS

  • About
    • Mission
    • Board of Directors
    • NANETS Structure
    • Staff
    • Committees
    • Committee Descriptions
    • NANETS Presidents
    • Lifetime Achievement
    • Outstanding Service
    • History
    • Diversity Statement
    • NANETS Awards
  • Education
    • NETCast Podcast Series
    • Regional NET Education
    • Virtual Programming Series
    • 2026 NET Medical Symposium
    • Conference Archives
    • About NETs
    • NANETS Call for Topics Calendar
  • Research
    • Abstracts Library
    • Abstract Instructions
    • Research Grants
    • Grant Recipients
  • Guidelines
  • Resources
    • Grant Resources
    • NANETS Mentorship Program
    • Employment Postings
    • Clinical Trials
    • Member DirectoryMember Directory
    • NET Around the World
    • Patient Resources
    • Women in NETs
    • COVID-19 Resource Page
    • NANETS Collaboration Submission Form
    • Provider Resources
  • News
    • NET eNews
    • Media
    • Endocrine-Related CancerEndocrine-Related Cancer
    • Photo Gallery
  • Membership
    • Member Login
    • Member Benefits
    • Member Categories
    • Join NOW
    • Spread the Word
    • Code of Conduct
  • 2025

  • 2024

  • 2023

  • 2022

  • 2021

  • 2020

  • 2019

  • 2018

  • 2017

  • 2016

  • 2015

  • 2014

  • 2013

  • 2012

  • 2011

  • 2010

  • 2009

[B10] Guenter - Notch1 and Notch3 signaling interplay regulates pancreatic neuroendocrine cell proliferation

Published in 2023 Listed under Basic Science

Download

[B11] Guenter - The Notch1 pathway is a critical regulator of SSTR2 expression in neuroendocrine tumors

Published in 2023 Listed under Basic Science

Download

[B12] Chen - Notch1 receptor-mediated metabolic flexibility promotes a survival advantage in pancreatic neuroendocrine neoplasms

Published in 2023 Listed under Basic Science

Download

[B13] Wang - Dissecting the role of neuronal mimicry in pancreatic neuroendocrine tumours

Published in 2023 Listed under Basic Science

Download

[B14] Zheng - Scandium-43-DOTATATE, a Novel Positron Emission Tomography (PET) Tracer for Neuroendocrine Tumor Imaging

Published in 2023 Listed under Basic Science

Download

[B15] Tow - Investigating serotonin metabolism in neuroendocrine cancers

Published in 2023 Listed under Basic Science

Download

[B16] Merlin - Chemotherapy-mediated upregulation of SSTR2 in NET tumors in mice and in tumor biopsies from lung- and gastroenteropancreatic-NET patients

Published in 2023 Listed under Basic Science

Download

[B17] Nanayakkara - YAP and TEAD form a transcriptional complex regulating neuroendocrine differentiation and tumorigenesis through a modular mechanism

Published in 2023 Listed under Basic Science

Download

[B18] Watkins - Identifying the relationship between neuroendocrine tumors (NET) and glutamic acid decarboxylase 65 (GAD65) antibody.

Published in 2023 Listed under Basic Science

Download

 

[B19] Knapp - Label-free phenotyping of duodenal neuroendocrine tumors using tissue autofluorescence microscopy and digital spatial profiling

Published in 2023 Listed under Basic Science

Download

[B1] Duan - Spatial profiling of neuro-immune interactions in gastroenteropancreatic NETs

Published in 2023 Listed under Basic Science

Download

[B20] Kulathunga - Establishment of novel PDXovo models for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs)

Published in 2023 Listed under Basic Science

Download

[B21] Sukrithan - Transcriptomic profiling of the BCL-2 pathway in Neuroendocrine Neoplasms (NENs)

Published in 2023 Listed under Basic Science

Download

[B22[ Sukrithan - Germline whole-exome sequencing of patients with neuroendocrine neoplasms (NENs) reveals pathogenic or likely pathogenic variants in a large subset of patients

Published in 2023 Listed under Basic Science

Download

[B23] Herring - Calreticulin is Associated with Clinical Characteristics in Pancreatic Neuroendocrine Tumors

Published in 2023 Listed under Basic Science

Download

[B24] Montoni - PARP inhibitors potentiate chemotherapy of NET cells and tumors and PAPR1-knockdown suppresses growth of NET tumors in mice#

Published in 2023 Listed under Basic Science

Download

[B25] Eagal - A STING Operation in neuroendocrine neoplasms

Published in 2023 Listed under Basic Science

Download

[B26] Seo - Cancer testis antigen and interleukin expression correlates with survival in small bowel neuroendocrine tumors

Published in 2023 Listed under Basic Science

Download

[B27] Forsythe - Development of GEP-NEN Patient Derived Organoids for Therapy Screening

Published in 2023 Listed under Basic Science

Download

[B28] Kaemmer - Therapies targeting CDK4/6 cause regression, immune cell activation, and sensitization to PD-L1 immunotherapy in pancreatic neuroendocrine tumors

Published in 2023 Listed under Basic Science

Download

[B2] Gonzalez-Cantu - TMEM127 exerts a tumor suppressive role in pheochromocytoma by mediating RET ubiquitindependent degradation

Published in 2023 Listed under Basic Science

Download

[B3] Nunez - Translational biomarkers in G2-3 NENs: Analysis from NET-001 and NET-002 trials

Published in 2023 Listed under Basic Science

Download

[B4] Kuehn - Cardiac autonomic dysfunction in a mouse model of carcinoid disease

Published in 2023 Listed under Basic Science

Download

[B5] Gorai - Unveiling Pancreatic Neuroendocrine Tumors through Plasma-Derived Small Extracellular Vesicles

Published in 2023 Listed under Basic Science

Download

[B6] Penrose - Prevalence of cardiac arrhythmias in a mouse model of carcinoid disease Sofia Penrose

Published in 2023 Listed under Basic Science

Download

[B7] Makinen - Genomic analyses of multifocal ileal neuroendocrine tumors

Published in 2023 Listed under Basic Science

Download

[B9] Daigle - Machine learning algorithm to classify multiphoton microscopy images of pancreatic neuroendocrine tumors

Published in 2023 Listed under Basic Science

Download

[C10] Gambardella - An ongoing phase I trial of the DLL3/CD3 IgG-like T-cell engager, BI 764532, in patients with DLL3-positive extrapulmonary neuroendocrine carcinomas

Published in 2023 Listed under Clinical

Download

[C11] McGlothlin - Transformation of Low-Intermediate Grade Neuroendocrine Tumors into High Grade Morphology

Published in 2023 Listed under Clinical

Download

[C12] Phillips - Real world use of virtual care for treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs)

Published in 2023 Listed under Clinical

Download

[C13] Eslinger - Clinical characteristics and molecular profiling of patients with pancreatic mixed acinar-neuroendocrine carcinoma

Published in 2023 Listed under Clinical

Download

[C14] Schnell - Cabozantinib as salvage therapy for well differentiated grade 3 neuroendocrine tumors (G3 NETs)

Published in 2023 Listed under Clinical

Download

[C15] Chauhan - Phase II study of frontline maintenance rucaparib in combination with nivolumab in extensive stage small cell lung cancer

Published in 2023 Listed under Clinical

Download

[C16] Khuong Le - Comparison of Well-differentiated Gastroenteropancreatic Grade 3 Neuroendocrine Tumors (G3NETs): De Novo and In The Setting of Apparent Grade Progression Over Time

Published in 2023 Listed under Clinical

Download

[C17] Ana - Argentinian Registry of Gastric Neuroendocrine Tumors: A closer look at Type 1

Published in 2023 Listed under Clinical

Download

[C18] Grage - [68Ga] DOTA-TATE (NETSpot) PET/CT Imaging of Pulmonary Neuroendocrine Tumors

Published in 2023 Listed under Clinical

Download

[C19] Yadav - The Impact of Post-Treatment Imaging in Peptide Receptor Radionuclide Therapy

Published in 2023 Listed under Clinical

Download

[C20] Yuan - Yttrium 90 transarterial radioembolization of neuroendocrine liver metastasis

Published in 2023 Listed under Clinical

Download

[C21] Lin - Ratio of total uptake volume on DOTATATE vs FDG PET as a predictive marker of treatment efficacy of Lu-177- DOTATATE in metastatic pheochromocytoma

Published in 2023 Listed under Clinical

Download

[C22] Lin - Phase 2 Trial of Lu-177-DOTATATE in Metastatic or Inoperable Pheochromocytoma/Paraganglioma: Interim Analysis Results

Published in 2023 Listed under Clinical

Download

[C23] Lin - Phase 1/2 study of Lu-177-DOTATATE in combination with olaparib in metastatic or inoperable GI neuroendocrine tumors - first results

Published in 2023 Listed under Clinical

Download

[C24] Nunez - 68Ga-DOTATATE/18F-FDG dual PET: Utility of the NETPET score in management of G2-3 WD NENs

Published in 2023 Listed under Clinical

Download

[C25] Fidelman - A Pilot Study of Pembrolizumab and Peptide Receptor Radionuclide Therapy for Patients with Metastatic Well- Differentiated Neuroendocrine Tumors

Published in 2023 Listed under Clinical

Download

[C26] Fidelman - A Pilot Study of Pembrolizumab and Embolization or 90Y Radioembolization for Patients with Metastatic Well- Differentiated Neuroendocrine Tumors

Published in 2023 Listed under Clinical

Download

[C27] Chauhan - ETCTN 10388: A first in human Phase I Trial of Triapine and Lutetium Lu 177 DOTATATE in Well-Differentiated Somatostatin Receptor-Positive Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)

Published in 2023 Listed under Clinical

Download

[C28] Chauhan - ETCTN 10450: A phase I trial of peposertib and lutetium 177 DOTATATE in well-differentiated somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

Published in 2023 Listed under Clinical

Download

[C29] Pelle - Small bowel ischemia in patients with midgut neuroendocrine tumors after treatment with 177Lutetium-Dotatate

Published in 2023 Listed under Clinical

Download

[C2] Urrego - Neuroendocrine tumor metastatic to breast: case report and review of the literature

Published in 2023 Listed under Clinical

Download

[C30] Lareef - Novel Alternate (Alt) Response Criteria for early outcome prediction in Pancreatic (P) Neuroendocrine Tumors (NETs): Utilizing banked imaging and radiomics

Published in 2023 Listed under Clinical

Download

[C31] Al-Ward - High-Specific-Activity Iodine-131-Meta-Iodo- Benzylguanidine for the Treatment of Advanced Pheochromocytoma and Paraganglioma: A Real-World Study

Published in 2023 Listed under Clinical

Download

[C32] Trikalinos - Myelodysplasia and leukemia instances after PRRT: Experience from a tertiary institution

Published in 2023 Listed under Clinical

Download

[C33] Salem - DOTATATE PET/CT Imaging In Prostate Cancer: Incidental Observations and Potential Future Implications

Published in 2023 Listed under Clinical

Download

[C34] Zaidi - Comparative Assessment of 111In-Octreotide Scintigraphy, 68Ga-DOTATOC PET/CT and 18F-FDG PET/ CT in the Staging and Management of Neuroendocrine Tumors (NETs)

Published in 2023 Listed under Clinical

Download

[C35] Wong - Institutional Retrospective Review of Peptide Receptor Radionuclide Therapy Use in Metastatic Paragangliomas and Pheochromocytomas

Published in 2023 Listed under Clinical

Download

[C36] Pletcher -vUtility of 68Ga-DOTATATE for Grade 3, Poorly Differentiated Gastroenteropancreatic Neuroendocrine Carcinoma

Published in 2023 Listed under Clinical

Download

[C37] Remick - Initial Experience Using 0.55T MRI for Detection of Liver Metastases in NET Patients

Published in 2023 Listed under Clinical

Download

[C38] Gupta - Are there any clinical factors associated with PRRTrefractoriness in NET patients?

Published in 2023 Listed under Clinical

Download

[C39] Grewal - Repeat Peptide Receptor Radionuclide Therapy in Neuroendocrine Neoplasms: A NET Center of Excellence Experience

Published in 2023 Listed under Clinical

Download

[C3] Vasconcelos - Real-World Evidence of Lenvatinib Use for Treatment of Metastatic Neuroendocrine Neoplasms

Published in 2023 Listed under Clinical

Download

[C40] Grewal - Evaluation of long-term hepatic adverse events in patients receiving Peptide Receptor Radionuclide Therapy (PRRT) following BLAND embolization

Published in 2023 Listed under Clinical

Download

[C41] Pritzl - Spectrum of therapy-related clonal cytopenias and neoplasms after exposure to Lutetium-177-Dotatate

Published in 2023 Listed under Clinical

Download

[C42] Luca - Treatment with Lutetium in a real-world setting: How does it affect patient experience and their time-toxicity?

Published in 2023 Listed under Clinical

Download

[C43] Zhang - Accuracy of DOTATATE PET Imaging in the Preoperative Planning of Small Bowel Neuroendocrine Tumor Resection

Published in 2023 Listed under Clinical

Download

[C44] Bell - Real-Time Prospective DAXX/ATRX Testing of 186 Consecutive Surgically Resected Pancreatic Neuroendocrine Tumors Reveals Loss of Expression Correlates with Distant Metastasis

Published in 2023 Listed under Clinical

Download

[C45] Lau - Grade progression in gastrointestinal neuroendocrine tumors

Published in 2023 Listed under Clinical

Download

[C46] Borbon - Peptide Receptor Radionuclide Therapy Improves Survival in Patients Who Progress After Resection of Gastroenteropancreatic Neuroendocrine Tumors

Published in 2023 Listed under Clinical

Download

[C47] Fasih - Surgical Cytoreduction vs Systemic therapy in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETS): NCDB Analysis.

Published in 2023 Listed under Clinical

Download

[C48] Wang - Predictors of low-to-high grade progression in pancreatic neuroendocrine tumors

Published in 2023 Listed under Clinical

Download

[C49] Meloche-Dumas - Post-procedure outcomes of liver-directed therapy of neuroendocrine liver metastases

Published in 2023 Listed under Clinical

Download

[C4] Mukherjee - Results from a Phase II study of nanoliposomal irinotecan (nal-IRI) with 5-fluorouracil (5-FU)/leucovorin in refractory advanced high-grade neuroendocrine cancer (HG-NEC)

Published in 2023 Listed under Clinical

Download

[C50] Worthy - Phenotype Genotype Correlation in Multiple Endocrine Neoplasia Type 1

Published in 2023 Listed under Clinical

Download

[C51] Partelli - A Prospective Phase II Single-Arm Trial on Neoadjuvant Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-DOTATATE Followed by Surgery for Pancreatic Neuroendocrine Tumors (NeoLuPaNET)

Published in 2023 Listed under Clinical

Download

[C52] AghaAmiri - Translational potential of a receptor-targeted contrast agent for fluorescence-guided applications in pancreatic neuroendocrine tumors

Published in 2023 Listed under Clinical

Download

[C54] Ng - Tissue section thickness of Ki67 immunohistochemistry does not have a correlative effect on pancreatic neuroendocrine tumor grading

Published in 2023 Listed under Clinical

Download

[C55] Al-Toubah - Association of long-term PPI use with low-risk gastric neuroendocrine tumor

Published in 2023 Listed under Clinical

Download

[C56] Laderian - Comparative gene expression and pathway analysis of neuroendocrine neoplasms in relation to clinical outcomes and tumor location

Published in 2023 Listed under Clinical

Download

[C57] Hallet - Perioperative management of carcinoid crisis: protocol for a modified Delphi international expert consensus statement with patient engagement

Published in 2023 Listed under Clinical

Download

[C58] Joseph - Do Pancreatic Well-differentiated Neuroendocrine Tumor (NET) Progress to Poorly-differentiated Neuroendocrine Carcinoma (NEC)?

Published in 2023 Listed under Clinical

Download

[C59] Nigam - High Grade Medullary Thyroid Carcinoma Predicts Greater Lymph Node Burden in the Ipsilateral Lateral Neck

Published in 2023 Listed under Clinical

Download

[C5] Jimenez - A phase 2 clinical trial of cabozantinib in patients with unresectable and progressive metastatic pheochromocytoma or paraganglioma: The NATALIE trial

Published in 2023 Listed under Clinical

Download

[C6] Kurian - The Role of Somatostatin Analogue Maintenance Therapy in Refractory Metastatic Neuroendocrine Tumors (NETs): Comparative Analysis

Published in 2023 Listed under Clinical

Download

[C7] Owen - A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms (NEN): Updated overall survival data

Published in 2023 Listed under Clinical

Download

[C8] Luo - Effect of Hepatic Impairment on Pharmacokinetics, Safety, and Tolerability of Oral Paltusotine, a Small- Molecule, Selective Somatostatin Receptor Subtype 2 Agonist

Published in 2023 Listed under Clinical

Download

[C9] Sukrithan - Anti-apoptosis as a therapeutic strategy in Neuroendocrine neoplasms (NEN): A case report

Published in 2023 Listed under Clinical

Download

[O10] Jones, Jr - Single Institution Retrospective Case Cohort of Adult Cyanotic Congenital Heart Disease and Associated Pheochromocytoma and Paraganglioma

Published in 2023 Listed under Other

Download

[O11] Huan - Head and Neck Paragangliomas: Overview of Institutional Experience

Published in 2023 Listed under Other

Download

[O12] Valdez - About a Case of Neuroendocrine Carcinoma of the Uterine Cervix in Peru

Published in 2023 Listed under Other

Download

[O1] Lister - Integrating Advance Care Planning into Nursing Work-flow

Published in 2023 Listed under Other

Download

[O2] Mohindroo - Germline Testing identifies Pathogenic/Likely Pathogenic Variants in Patients with Pancreatic Neuroendocrine Tumors

Published in 2023 Listed under Other

Download

[O3] Storandt - Clinical characteristics of mixed neuroendocrine nonneuroendocrine neoplasm (MiNEN): a single institution case series

Published in 2023 Listed under Other

Download

[O4] Moon - Baseline grade discordance in patients with pancreatic neuroendocrine tumors (PanNETs)

Published in 2023 Listed under Other

Download

[O5] Meng - Chromogranin A as Surveillance biomarker in Patients with cARcinoids (CASPAR)

Published in 2023 Listed under Other

Download

[O6] Ferone - PRESTO 3: An international, simulated-use study assessing preferences of nurses between two lanreotide syringes (Somatuline® Autogel® versus Pharmathen)

Published in 2023 Listed under Other

Download

[O7] Vadehra - Demographic characteristics and survival in young onset colorectal neuroendocrine tumors

Published in 2023 Listed under Other

Download

[O8] Aggarwal - Comparison of endoscopic ultrasound fine needle aspiration (FNA) versus fine needle biopsy (FNB) for preoperative grading of pancreatic neuroendocrine tumors: A systematic review and meta-analysis

Published in 2023 Listed under Other

Download

[O9] Sonbol - Prevalence of clonal hematopoiesis (CH) in neuroendocrine tumor (NET) patients prior to lutetium 177 Dotatate (Lu177): A prospective study

Published in 2023 Listed under Other

Download

[P10] Mulvey - Quality of Life Differs by Age and Sex for Participants with Advanced Neuroendocrine Neoplasms in the eNET Study

Published in 2023 Listed under P

Download

[P11] Tan - Sex Differences during Hospital Stay among Patients with Neuroendocrine Neoplasms

Published in 2023 Listed under P

Download

[P1] Paciorek - Rising incidence of bronchopulmonary neuroendocrine tumors

Published in 2023 Listed under P

Download

[P2] Pena - Renal Neuroendocrine Tumors: A Single Center Clinicopathologic and Molecular Analysis

Published in 2023 Listed under P

Download
  • 1
  • 2
  • »

NANETS

167 Madison Avenue, Suite 205, #646 | New York, NY 10016
(718) 283-4783 | staff@nanets.net

Member Login

Twitter Facebook LinkedIn
  • Privacy Policy
  • |
  • Site Map

Copyright ©2026 ADG. All Rights Reserved | Web Design & Development by ADG Creative, a division of ADG.
ADG is a certified Women Owned Business.